Core Viewpoint - The A-share market has achieved significant milestones, with the Shanghai Composite Index closing at 4083.67 points, marking a ten-year high and a record 13 consecutive days of gains, indicating strong investor confidence and a potential shift towards a balanced bull market in 2026 [1][3][7]. Market Performance - On January 6, all three major A-share indices rose, with the Shanghai Composite Index up 1.50%, surpassing last year's high and achieving a new ten-year peak [3]. - The market saw a trading volume of 2.83 trillion yuan, reflecting heightened investor enthusiasm [1]. - The brain-computer interface sector experienced a surge, with nearly 20 stocks hitting the daily limit, while the commercial aerospace sector also saw significant gains [3]. Sector Analysis - Key sectors leading the market included non-ferrous metals, non-bank financials, basic chemicals, and defense industries, driven by expectations of global supply chain restructuring and strong performance in the insurance and brokerage sectors [4][6]. - The Wenke Brain-Computer Interface Index rose by 12.97%, and the Commercial Aerospace Index increased by 9.49% in the first two trading days of 2026 [3]. Fund Flow and Investment Strategies - There is a strong expectation for capital inflow into the market, particularly from insurance companies, which saw a significant increase in new premium funds available for market allocation [5][6]. - As of September 2025, insurance funds allocated to stocks and funds reached 5.59 trillion yuan, an increase of 1.49 trillion yuan since the beginning of the year [6]. - The financing balance reached a historical high of 2.54 trillion yuan on January 5, 2026, indicating robust market liquidity [6]. Future Market Outlook - Analysts predict a transition from valuation-driven growth in 2025 to profit-driven growth in 2026, with a more balanced market style emerging [7]. - The market is expected to maintain an upward trend, supported by macroeconomic recovery, with key sectors such as technology, consumer goods, and new energy likely to see rotation and valuation recovery [7][9]. Investment Recommendations - Investment firms suggest a balanced allocation strategy, focusing on growth sectors like AI, while also considering defensive assets such as non-ferrous metals and chemicals [11][12]. - Emphasis is placed on long-term investment in sectors with strong fundamentals, avoiding short-term speculative trading [11][12].

1月6日晚，亚辉龙（688575）披露近日与深圳脑机星链科技有限公司（简称"脑机星链"）签署战略合作框架协议。当晚，上交所对公司下发问询函。 公司当晚补充披露，合作方脑机星链目前在研产品的技术路线为非侵入式技术路径，与马斯克创建的脑机接口公司Neuralink在技术路线上存在本质区别， 目前也尚无侵入式技术布局。 合作方成立不到半年 股价提前异动 1月6日晚，亚辉龙公告，公司与脑机星链签署《战略合作框架协议》。合作内容包括，通过公司在急诊、脑疾病诊断、儿科等领域强大的销售渠道为脑机 星链脑机接口现有及在研产品的市场拓展及销售进行全方位赋能，合作产生的销售收入按照双方后续协议比例进行分成。结合公司在儿科、脑神经疾病、 代谢等方向强大的专家、学术资源以及脑机星链在脑机接口领域优秀技术团队及研发实力，加强研发合作。双方一致同意，经双方有权机构批准，同等条 件下优先选择对方进行资本和股权层面的合作。该协议为框架性协议，不涉及具体金额，预计对公司本年度经营业绩不构成重大影响。 据亚辉龙公告，公司为体外诊断产品提供商，主营业务为以化学发光免疫分析法为主的体外诊断仪器及配套试剂的研发、生产和销售。 脑机星链成立于2025年 ...

Group 1: Stock Market Performance - The brokerage sector has collectively risen, with the non-bank financial sector up by 3.73% as of January 6, 2026, benefiting from the spring market and public fund reforms [1] - The A-share market has shown strong performance, with all three major indices rising, and the Shanghai Composite Index achieving a "thirteen consecutive days" increase, reaching a ten-year high [1] - The total market capitalization of A-shares has surpassed 122 trillion yuan, setting a new historical record, with a trading volume of 2.83 trillion yuan on January 6 [1] Group 2: Human-shaped Robot Industry - The human-shaped robot sector is gaining attention, with a 12.92% increase in the human-shaped robot concept index since December 17, 2025 [2] - Analysts believe the market for embodied robots has significant growth potential, with continuous technological breakthroughs and successful commercialization [2] Group 3: Monetary Policy and Economic Outlook - The People's Bank of China has outlined seven key priorities for 2026, emphasizing the use of various monetary policy tools to support economic stability and high-quality development [3] - The central bank aims to enhance financial services for the real economy and improve macroeconomic policy coordination [3] Group 4: Commercial Aerospace and Satellite Internet - The commercial aerospace sector has seen a surge in stock prices, with leading companies experiencing significant gains, such as China Satellite up over 165% [4] - Analysts recommend focusing on core suppliers within the industry chain, including satellite assembly and key component suppliers [4] Group 5: New Account Openings in A-shares - In December 2025, the Shanghai Stock Exchange reported 2.5967 million new A-share accounts, a 9% increase from the previous month and a 30.55% year-on-year growth [5] - The monthly new account openings showed a wave-like trend throughout 2025, with peaks and troughs reflecting market conditions [5] Group 6: Solid-State Battery Industry - The solid-state battery sector is gaining traction, with significant interest following the announcement of the world's first mass-producible solid-state battery at CES 2026 [7] - The industry is undergoing a transformation towards value competition, focusing on technology and performance rather than just scale [7] Group 7: Brokerage Asset Management - The asset management business of brokerages has shown steady growth, with private asset management scale reaching 5.8 trillion yuan by the end of November 2025 [8] - Brokerages are increasingly focusing on research capabilities and exploring differentiated development paths in asset management [8]

转自：证券时报 在A股市场持续走强并刷新10年新高的同时，中证转债指数1月6日也攀升走高，创下自2015年6月以来 的逾10年高点。 中证转债指数近期表现不仅延续了自2025年以来的强势格局，更凸显其在权益市场波动中"进可攻、退 可守"的独特价值。 中证转债指数刷新逾10年高点 1月6日，在权益市场强势走高，并刷新10年新高的背景下，中证转债指数也大涨1.35%，报505.77点， 创2015年6月以来高点。 此次行情的核心催化剂是脑机接口行业的商业化突破。特斯拉CEO埃隆·马斯克于2025年12月31日宣 布，旗下脑机接口公司Neuralink将于2026年启动设备大规模生产，并推进几乎完全自动化的手术方案。 这一表态被市场视为脑机接口从实验室走向大众消费的关键转折点。与此同时，国内政策支持力度持续 加码：国家药监局近期召开脑机接口医疗器械工作推进会，明确将加快相关产品审评审批流程；上海等 地出台专项行动方案，提出到2027年推动5款以上侵入式、半侵入式产品完成临床试验。 除塞力转债外，嘉美转债、联创转债等亦表现亮眼。嘉美包装股价大涨带动嘉美转债在1月5日涨 10.94%后，1月6日再度上涨14.95%，2 ...

Group 1 - The central bank will continue to implement a moderately loose monetary policy and increase counter-cyclical and cross-cyclical adjustment efforts [1] - Strong Brain Technology, a "unicorn" in brain-computer interface, has completed financing of approximately 2 billion yuan [1] - The Ministry of Commerce will strengthen export controls on dual-use items to Japan [1] Group 2 - The State Administration of Foreign Exchange is advancing the revision of the Foreign Exchange Management Regulations to build a higher standard international balance of payments statistical system [1] - In 2026, China will launch over 30 national standards in the data field [1] - Investment in water conservancy construction in China has exceeded 1 trillion yuan for four consecutive years [1] Group 3 - The China Automobile Dealers Association expects the automotive market to show a "good start" in January [1] - The State Administration of Foreign Exchange will orderly expand high-level opening pilot projects for cross-border trade and increase support for new trade formats such as cross-border e-commerce [1]

Group 1 - The core viewpoint of the news is that the brain-computer interface (BCI) sector is experiencing significant growth, highlighted by the recent 2 billion yuan financing of Qiangnao Technology, marking it as the second-largest financing in the field after Neuralink [2][3] - The BCI sector has become the hottest investment track in the A-share market since the beginning of 2026, with multiple stocks like Innovation Medical, Aipeng Medical, and Xiangyu Medical achieving consecutive trading limits [2] - Qiangnao Technology is recognized as one of the "Hangzhou Six Little Dragons," focusing on the research and development of BCI products, and has received FDA and CE certifications, making it one of the largest investors in BCI R&D globally [3][4] Group 2 - Qiangnao Technology was founded in February 2015 and has launched several products, including smart bionic limbs and brain-machine intelligent sleep devices [3] - The company has a strong investor lineup, including IDG, Huaden International, and several strategic investors, indicating robust market confidence [3] - The BCI industry is currently in a high-growth phase driven by policy support and technological breakthroughs, with expectations for Neuralink to begin large-scale production in 2026 [4] Group 3 - Several BCI stocks, including Sanbo Brain Science, Maillande, and Xiangyu Medical, have issued announcements regarding abnormal stock trading fluctuations, warning investors of potential risks [5] - Sanbo Brain Science reported a significant stock price increase but clarified that it does not engage in BCI product development, indicating minimal impact on its financial performance [7] - Xiangyu Medical highlighted its focus on non-invasive BCI technology and aims to commercialize its products in over a thousand top-tier hospitals by 2026 [11]

据商务部消息，根据《中华人民共和国出口管制法》等法律法规有关规定，为维护国家安全和利益、履 行防扩散等国际义务，决定加强两用物项对日本出口管制。现将有关事项公告如下： 禁止所有两用物项对日本军事用户、军事用途，以及一切有助于提升日本军事实力的其他最终用户用途 出口。 任何国家和地区的组织和个人，违反上述规定，将原产于中华人民共和国的相关两用物项转移或提供给 日本的组织和个人，将依法追究法律责任。 消息人士：中方正研究收紧对日稀土出口许可审查 中国日报援引可靠消息人士称，鉴于日本近期恶劣表现，中国政府正考虑针对性收紧2025年4月4日列管 的中重稀土相关物项出口许可审查。 2025年4月4日，根据《中华人民共和国出口管制法》等有关法律法规，商务部会同海关总署发布关于对 钐、钆、铽、镝、镥、钪、钇等7类中重稀土相关物项实施出口管制措施的公告，并于发布之日起正式 实施。 【头条要闻】 商务部：加强两用物项对日本出口管制 中方提醒：日本应完全解除武装！ 据报道，日本首相高市早苗日前称将以年内修订"安保三文件"为目标。外交部发言人毛宁1月6日在例行 记者会上表示，这反映出日本加速推进"再军事化"的危险动向，国际社会必须 ...

Core Viewpoint - BrainCo, a prominent brain-computer interface (BCI) company in Hangzhou, has gained global attention due to its non-invasive technology and mass production capabilities, positioning itself as a competitor to Neuralink [1][2]. Group 1: Company Overview - Founded in 2015 by Harvard alumnus Han Bicheng, BrainCo is recognized as China's first BCI unicorn and has made significant advancements in non-invasive technology [1][2]. - The company has received major international certifications, including FDA and CE, and ranks among the top in global BCI research and development investments [2]. - BrainCo's flagship product, the BrainRobotics smart bionic hand, has been featured on the cover of TIME magazine's Best Inventions of the Year [2]. Group 2: Technological Innovations - BrainCo's core technology, the super sensor, captures weak brain signals without invasive procedures, enabling applications in rehabilitation for disabled individuals and treatment for conditions like autism and Alzheimer's [4]. - The company has successfully launched products such as the smart bionic hand and bionic leg, which allow users to perform complex movements, showcasing the practical impact of BCI technology [4]. Group 3: Market Position and Financing - BrainCo recently completed a financing round of approximately 2 billion RMB, making it the second-largest financing in the global BCI sector after Neuralink [5]. - The investment consortium includes renowned firms like IDG and strategic partners such as Lens Technology, indicating strong market confidence in BrainCo's potential [5]. - The company is preparing for an IPO, with plans to list in Hong Kong or on the STAR Market, reflecting its growth trajectory and market ambitions [5]. Group 4: Future Prospects - Han Bicheng envisions BCI technology transforming everyday life, with plans to assist 1 million disabled individuals and 10 million patients with brain-related conditions over the next 5 to 10 years [7]. - The demand for BCI solutions is significant, given that over 24 million people in China live with physical disabilities, alongside rising cases of brain diseases [7]. - BrainCo's growth is supported by Hangzhou's favorable innovation environment and government funding, which has been crucial for its development [8].

Core Viewpoint - The article highlights the rapid growth and investment activity in the brain-computer interface (BCI) sector, particularly focusing on the recent significant financing of Qiangnao Technology, which has raised approximately 2 billion yuan, marking it as the second-largest financing in the BCI field globally after Neuralink [2][3]. Investment Landscape - The BCI sector has emerged as a hot investment area in the A-share market since the beginning of 2026, with multiple stocks such as Innovation Medical, Aipeng Medical, and Xiangyu Medical experiencing consecutive trading gains [2]. - Qiangnao Technology, part of the "Hangzhou Six Little Dragons," has attracted a strong lineup of investors, including IDG and major tech firms, and has received FDA and CE certifications for its products [3][4]. Company Developments - Qiangnao Technology, founded in 2015, focuses on non-invasive BCI technology and has launched several products, including smart bionic limbs and brain-machine sleep aids [3]. - The company has a history of significant funding rounds, including a $400 million Series A round in 2019 and subsequent rounds totaling $30 million and $20 million in 2025 [4]. Market Dynamics - The BCI industry is currently experiencing a dual boost from policy support and technological breakthroughs, with expectations for Neuralink to begin large-scale production of BCI devices in 2026 [4]. - Companies like Sanbo Brain Science, Meilan De, and Xiangyu Medical have issued announcements regarding stock trading volatility, indicating the heightened interest and speculative nature of the market [5][6]. Product and Technology Focus - Xiangyu Medical is concentrating on non-invasive BCI technology and has made significant investments in R&D, with over 60% of its R&D budget directed towards BCI-related projects [7]. - The company aims to integrate BCI technology with its rehabilitation equipment, targeting to cover over 1,000 top-tier hospitals by 2026 [7].

消息面上，被称作"杭州六小龙"之一的强脑科技近日完成约20亿元融资。此外，马斯克在社交媒体上表 示，其脑机接口公司"神经连接"将于2026年开始对脑机接口设备进行"大规模生产"。 连板股密集公告 "20CM2连板"三博脑科（301293）1月6日晚间发布股票交易异动公告称，公司是以神经专科为特色的医 疗服务集团，下属院区主要为患者提供以高精尖神经外科为主的综合医疗服务。公司目前不涉及脑机接 口产品的研发、生产及销售，神经调控技术带来的收入占公司营业收入比重很小，对公司业绩基本没有 影响，敬请注意投资风险。 "2连板"航天长峰（600855）1月6日晚间发布股票交易异动公告称，经自查，公司关注到公司被列为脑 机接口、商业航天等相关概念股。公司主营业务分为军工电子、公共安全和高端医疗装备三大板块，公 司主营业务未发生改变，目前公司未实际开展脑机接口等相关业务、不从事商业航天相关业务。除此之 外，公司未发现对公司股票交易价格可能产生重大影响的需要澄清或回应的媒体报道或市场传闻，未发 现其他对公司股票交易价格产生影响的媒体报道或市场传闻。 近期，A股脑机接口概念股大涨。数据显示，1月6日，脑机接口指数大涨超4%，创历 ...